Will procalcitonin reduce antibiotic use in intensive care?
- PMID: 20097416
- DOI: 10.1016/S0140-6736(10)60140-7
Will procalcitonin reduce antibiotic use in intensive care?
Comment on
-
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.
Similar articles
-
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.
-
Procalcitonin in intensive care units: the PRORATA trial.Lancet. 2010 May 8;375(9726):1605; author reply 1606-7. doi: 10.1016/S0140-6736(10)60694-0. Lancet. 2010. PMID: 20452515 No abstract available.
-
Procalcitonin in intensive care units: the PRORATA trial.Lancet. 2010 May 8;375(9726):1605; author reply 1606-7. doi: 10.1016/S0140-6736(10)60695-2. Lancet. 2010. PMID: 20452513 No abstract available.
-
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.Intensive Care Med. 2015 Oct;41(10):1739-51. doi: 10.1007/s00134-015-3978-8. Epub 2015 Jul 21. Intensive Care Med. 2015. PMID: 26194026 Review.
-
Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.Crit Care Med. 2010 Nov;38(11):2229-41. doi: 10.1097/CCM.0b013e3181f17bf9. Crit Care Med. 2010. PMID: 20729729 Review.
Cited by
-
Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection.BMC Emerg Med. 2017 Aug 29;17(1):25. doi: 10.1186/s12873-017-0138-1. BMC Emerg Med. 2017. PMID: 28851296 Free PMC article. Clinical Trial.
-
Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.BMC Infect Dis. 2013 Apr 16;13:178. doi: 10.1186/1471-2334-13-178. BMC Infect Dis. 2013. PMID: 23590389 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical